CC

Chandrashekhar Chindhuji Tembhurkar

Active Director Director DIN 11433430
DIN 11433430 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandrashekhar Chindhuji Tembhurkar

Data last updated:

Chandrashekhar Chindhuji Tembhurkar is a Director at Busshin Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11433430
Primary Designation Director
Industry Pharma
First Appointment 16 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Dec 20252025Active

Board colleagues of Chandrashekhar Chindhuji Tembhurkar

NameDINCompanyDesignation
Kunal Tembhurkar11433429Busshin Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Busshin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandrashekhar Chindhuji Tembhurkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrashekhar Chindhuji Tembhurkar

Chandrashekhar Chindhuji Tembhurkar currently holds 1 directorship: Busshin Pharmaceuticals Private Limited (Director, since 16 Dec 2025).

Chandrashekhar Chindhuji Tembhurkar was first appointed on 16 Dec 2025 as Director at Busshin Pharmaceuticals Private Limited.

The current boards of Chandrashekhar Chindhuji Tembhurkar's companies include Kunal Tembhurkar (Busshin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available